GMED: Globus Medical, Inc.
About
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
Current Value
$83.231 Year Return
Current Value
$83.231 Year Return
Key Details
Market Cap
$11.35B
P/E Ratio
125.69
1Y Stock Return
81.49%
1Y Revenue Growth
102.10%
Dividend Yield
0.00%
Price to Book
2.8
Strategies that include GMED
Stock's related to GMED
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LPX | 52.96% | $7.84B | +85.45% | 0.70% |
| VTOL | 49.30% | $1.07B | +42.07% | 0.00% |
| KD | 48.04% | $6.51B | +55.09% | 0.00% |
| HY | 47.15% | $948.82M | +15.25% | 2.47% |
| KMT | 46.49% | $2.17B | +21.08% | 2.88% |
| VRTS | 45.03% | $1.63B | +19.88% | 3.42% |
| IBTX | 44.96% | $2.62B | +67.52% | 2.41% |
| SPNS | 43.66% | $1.52B | +6.33% | 2.13% |
| ELAN | 43.63% | $6.58B | +12.99% | 0.00% |
| MYGN | 42.89% | $1.37B | -14.19% | 0.00% |
| SXI | 42.67% | $2.46B | +49.61% | 0.60% |
| VBTX | 42.32% | $1.58B | +53.68% | 2.75% |
| WTFC | 41.68% | $8.72B | +56.17% | 1.38% |
| PPBI | 41.53% | $2.67B | +20.00% | 4.75% |
| BY | 41.39% | $1.36B | +51.33% | 1.18% |
| SNV | 41.16% | $7.82B | +84.71% | 2.75% |
| WSFS | 41.11% | $3.39B | +48.16% | 1.02% |
| FULT | 41.02% | $3.77B | +47.51% | 3.27% |
| FRME | 41.01% | $2.51B | +38.53% | 3.21% |
| SASR | 40.79% | $1.67B | +66.20% | 3.68% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SE | 0.04% | $60.12B | +197.12% | 0.00% |
| FRPT | -0.07% | $7.59B | +126.44% | 0.00% |
| KRRO | 0.09% | $436.84M | +20.68% | 0.00% |
| BCOV | 0.10% | $133.15M | +17.06% | 0.00% |
| RTX | 0.17% | $158.34B | +52.22% | 2.09% |
| K | -0.19% | $27.77B | +52.50% | 2.79% |
| NOC | -0.20% | $71.54B | +4.23% | 1.60% |
| CHH | -0.20% | $6.84B | +27.72% | 0.79% |
| RAMP | -0.25% | $1.86B | -16.17% | 0.00% |
| RDY | -0.27% | $11.97B | +5.10% | 3.31% |
| T | 0.28% | $163.09B | +40.40% | 4.87% |
| PEP | -0.31% | $215.02B | -6.60% | 3.35% |
| GALT | 0.34% | $172.91M | +41.28% | 0.00% |
| OCFT | 0.37% | $80.95M | -30.38% | 0.00% |
| RBRK | -0.41% | $8.03B | +38.16% | 0.00% |
| GAN | 0.46% | $83.39M | +21.19% | 0.00% |
| CHD | -0.56% | $27.18B | +19.50% | 1.03% |
| IRWD | -0.59% | $609.71M | -59.34% | 0.00% |
| AHR | 0.60% | $4.30B | +134.17% | 2.69% |
| CASI | 0.60% | $71.56M | -6.32% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| DV | -28.69% | $3.26B | -37.48% | 0.00% |
| TRIP | -21.64% | $1.87B | -29.46% | 0.00% |
| ODP | -17.92% | $777.35M | -46.62% | 0.00% |
| GO | -14.66% | $1.81B | -34.42% | 0.00% |
| INSP | -14.27% | $5.28B | +27.64% | 0.00% |
| MNR | -14.06% | $1.66B | -10.71% | 15.90% |
| TMCI | -12.43% | $483.43M | -8.71% | 0.00% |
| LZ | -11.89% | $1.30B | -33.57% | 0.00% |
| ZI | -11.38% | $3.40B | -28.47% | 0.00% |
| MCK | -11.35% | $78.15B | +35.51% | 0.42% |
| CPNG | -10.37% | $43.51B | +49.69% | 0.00% |
| NRC | -9.98% | $442.05M | -55.00% | 2.56% |
| SIGA | -9.86% | $446.99M | +29.99% | 0.00% |
| NATR | -9.40% | $295.06M | -7.42% | 0.00% |
| NOVA | -9.04% | $429.84M | -67.33% | 0.00% |
| BGS | -8.98% | $503.48M | -32.20% | 12.01% |
| PULM | -8.90% | $19.83M | +202.98% | 0.00% |
| EYE | -7.99% | $888.30M | -42.18% | 0.00% |
| YMAB | -7.92% | $486.41M | +106.46% | 0.00% |
| FLYW | -7.82% | $2.79B | -0.88% | 0.00% |
ETF's related to GMED
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| AIRR | 42.05% | $2.51B | 0.7% |
| DFSV | 41.63% | $4.16B | 0.31% |
| FNCL | 41.58% | $2.03B | 0.084% |
| VO | 41.54% | $73.70B | 0.04% |
| VFH | 41.53% | $11.71B | 0.1% |
| SLYV | 41.49% | $4.16B | 0.15% |
| VIOV | 41.47% | $1.44B | 0.15% |
| IUSV | 41.46% | $19.83B | 0.04% |
| IAT | 41.45% | $725.82M | 0.4% |
| KBE | 41.41% | $2.42B | 0.35% |
| FXO | 41.40% | $1.02B | 0.62% |
| MDYV | 41.21% | $3.25B | 0.15% |
| FSMD | 41.21% | $583.89M | 0.15% |
| IJJ | 41.19% | $8.03B | 0.18% |
| IVOV | 41.18% | $964.95M | 0.15% |
| KBWB | 41.15% | $2.52B | 0.35% |
| DFAT | 41.15% | $11.16B | 0.28% |
| SMDV | 41.15% | $754.57M | 0.4% |
| SMIG | 41.10% | $683.20M | 0.6% |
| IAI | 41.03% | $1.72B | 0.4% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| FTSM | 0.26% | $6.08B | 0.45% |
| IBDP | -0.49% | $2.11B | 0.1% |
| JBBB | 0.50% | $1.26B | 0.49% |
| KRBN | 0.63% | $242.47M | 0.85% |
| CCOR | 0.71% | $109.04M | 1.18% |
| SOYB | -0.78% | $27.32M | 0.22% |
| SHYD | -0.86% | $311.50M | 0.35% |
| CLOI | 0.91% | $715.40M | 0.4% |
| WEAT | -1.12% | $120.27M | 0.28% |
| XBIL | -1.25% | $637.70M | 0.15% |
| GOVZ | 1.30% | $313.00M | 0.1% |
| UCON | -1.63% | $3.19B | 0.85% |
| MINT | 1.73% | $11.62B | 0.35% |
| ULST | 1.76% | $535.47M | 0.2% |
| JPST | 1.81% | $28.43B | 0.18% |
| XHLF | -1.96% | $874.27M | 0.03% |
| TBIL | 1.96% | $4.38B | 0.15% |
| BOXX | 1.97% | $4.43B | 0.1949% |
| FMF | 1.98% | $244.61M | 0.95% |
| YEAR | 2.10% | $1.13B | 0.25% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -23.47% | $195.31M | 0.85% |
| BTAL | -22.58% | $388.04M | 1.43% |
| TAIL | -22.47% | $67.98M | 0.59% |
| BSCO | -14.37% | $2.35B | 0.1% |
| MUNI | -14.25% | $1.73B | 0.35% |
| DFNM | -11.60% | $1.40B | 0.17% |
| CGMU | -11.10% | $2.53B | 0.27% |
| IBMM | -9.90% | $391.28M | 0.18% |
| CTA | -9.78% | $350.27M | 0.78% |
| UUP | -8.15% | $309.25M | 0.77% |
| USDU | -8.12% | $201.97M | 0.5% |
| CORN | -7.95% | $61.12M | 0.2% |
| KCCA | -7.15% | $220.51M | 0.87% |
| JUCY | -7.00% | $324.29M | 0.6% |
| BILZ | -5.92% | $563.02M | 0.14% |
| EQLS | -5.52% | $76.08M | 1% |
| KMLM | -4.97% | $353.87M | 0.9% |
| DUSB | -4.67% | $797.63M | 0.15% |
| HDRO | -2.89% | $164.26M | 0.3% |
| XHLF | -1.96% | $874.27M | 0.03% |
News
Yahoo
A few of its recent strategic acquisitions that are likely to drive future growth for TMO include the $3.1-billion acquisition of Olink Holdings.
Yahoo
SYK launches the Oculan Lighting Platform to improve lighting conditions in the operating rooms and allow surgeons to perform with more accuracy.
Yahoo
Zimmer Biomet gets CE Mark Certification for Persona Revision Knee System, followed by the successful introduction in the United States and other markets.
Yahoo
Illumina's new TSO 500 v2 assay aims to enable CGP of tumors, bolstering its TruSight Oncology portfolio.
Yahoo
PDCO's latest agreement with PDS Health to extend their deal is likely to streamline operations, optimize efficiency and maximize profitability.
Yahoo
MDT delivers diversified growth across all its segments in the second quarter of fiscal 2025.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.